报价延迟最少15分钟:2025/09/15 09:03 EDT
盘前时段
|
||||
|
14.98 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
--
|
|
|
| 价值评估 |
|
盈利(现时/预测)
42.76/106.02
|
|
企业价值
4,014.02B
|
| 资产负债 |
|
每股账面净值
14.75
|
| 现金流量 |
|
现金流量率
0.15
|
| 损益表 |
|
收益
4,581.55B
|
|
每股收益
8.81
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/09/15 09:03 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada. |
